SCN5A and cardiac arrhythmia: These findings demonstrate that θ′ alternans was marked in the flecainide-treated Scn5a+/− RV epicardium, which is the site previously implicated in the initiation of arrhythmia (Matthews et al. 2012), potentially suggesting their role in the arrhythmogenic mechanism.